FDAnews Drug Daily Bulletin

SIRION THERAPEUTICS SETS ITS SIGHTS ON OPHTHALMIC HEALTH

June 20, 2006
A A

Founded with a mission to protect and preserve the gift of sight, executives from the newly created Sirion Therapeutics, Inc. unveiled their new company today. The announcement was made by co-founders Barry Butler, Chairman and Chief Executive Officer; Roger Vogel, MD, Chief Medical Officer; Susan Benton, Chief Commercial Officer; and Philippe Boulangeat, Chief Business Officer.
PR Newswire